Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

Investment analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued to clients and investors on Monday. The brokerage set a “buy” rating on the stock.

Mannatech Trading Down 0.9 %

Shares of NASDAQ:MTEX opened at $8.05 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. Mannatech has a 1 year low of $6.75 and a 1 year high of $10.51. The company has a market cap of $15.13 million, a P/E ratio of -9.94 and a beta of 1.17. The stock’s fifty day moving average price is $7.78 and its 200-day moving average price is $7.54.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The company had revenue of $31.73 million for the quarter.

Insiders Place Their Bets

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the transaction, the director now owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This represents a 22.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 41.50% of the stock is currently owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.